NOAHE Rounds II Session 8: Methods for Estimating the Cost-Effectiveness Threshold

Health budgets in Canada are under pressure due to increasing demand for care and the adoption of new, costly technologies. Since budgets are constrained, funding new technologies requires reallocation of resources away from existing services, with implications for the health of patients in need of these services. Policy makers use cost effectiveness (CE) analyses to understand the implications of these funding decisions. However, without a measure of “value for money”, CE analyses by themselves are unable to illustrate the overall impact of new technologies on population health. Appropriate CE thresholds would allow policy makers to use CE analyses to compare the health gains from new technologies to the health forgone due to the necessary resource reallocations.

Despite the importance of CE thresholds, and the expressed need for them by policy makers and academics, no such estimates currently exist in Canada. Without a CE threshold, interpretation of CE analyses is problematic and relies solely on arbitrary rules, expert judgment and the advocacy of interested parties.

The objective of this session is to discuss the methods for estimating the cost-effectiveness threshold and report on a current analysis of an estimate of the cost-effectiveness threshold for cancer care in Alberta.


Eldon Spackman Profile PictureDr. Eldon Spackman, Institute for Public Health, University of Calgary

Event Details

Date: Wednesday, May 22, 2019
Time: 2:00 pm MT
Location: Room G801E, 3330 Hospital Drive NW, Health Sciences Building, University of Calgary, Calgary AB


Please click the following link to register for this event:

Live Webcast

Please click the following link to register to view the live webcast:


Upcoming Rounds

June 19, 2019, Institute of Health Economics - James O'Mahony, Trinity College Dublin